Darren Fast

Current

CEO at DiagKNOW
President at Solalta Advisors Ltd.

Past

Chief Technology Officer at Lombard Life Sciences
Manager, Product Planning and Development at Viventia Biotech Inc.

Education

University of Alberta
University of Manitoba
University of Manitoba

see less...

Recommended

1 person has recommended Darren

Connections

88 connections

Industry

Biotechnology

Websites

Darren Fast’s Summary

An accomplished executive with excellent communication skills, and proven ability in problem solving, team building, strategic planning, business development and venture capital within the early stage life-sciences sector. Demonstrated expertise in technology and market evaluation, in-licensing, company formation, project management, clinical trials, product development, and commercialization. A results-oriented professional committed to personal and organizational success.

PROFESSIONAL EXPERTISE
• Well-developed entrepreneurial discernment with exceptional organizational and coordinating strengths for the start up of new business ventures in the life-sciences sector.
• Visionary strategic planner with a keen ability to identify and assess the highly regulated development pathway for complex product development of novel therapeutics and medical devices and a clear ability to build plans and budgets for the future.
• Effective leadership and team building strengths: able to analyze requirements, identify skills and motivate a team to successfully complete projects on time and on budget.
• Innovative problem solver and decision-maker; able to proactively develop and implement efficient solutions to challenges in a variety of work environments.
• A passion for commercialization of early stage technologies and products in the area of human health.

Darren Fast’s Specialties:

Licensing, product development, project management, market analysis, venture capital, strategic planning, portfolio management, business planning.

Darren Fast’s Experience

CEO

DiagKNOW

(Privately Held; 1-10 employees; Health, Wellness and Fitness industry)

January 2008 — Present (7 months)

DiagKNOW provides a physiological dashboard tracked over time as a tool that you can use to manage your lifestyle choices over time.
President

Solalta Advisors Ltd.

(Privately Held; 1-10 employees; Biotechnology industry)

November 2005 — Present (2 years 9 months)

Solalta Advisors exists to assist companies and institutions with commercial development of life-sciences technologies and products. We do this by carrying out scientific, market and commercial due diligence of biotechnology and pharmaceutical technologies and potential commercial partners. We also assist with technology transfer and licensing; project and portfolio management; business planning, development and management services.
Chief Technology Officer

Lombard Life Sciences

(Privately Held; 1-10 employees; Biotechnology industry)

February 2002 — December 2005 (3 years 11 months)

Lombard Life Sciences is the General Manager for the Western Life Sciences Venture Fund LP a $45M Cdn. fund established to create, acquire, and develop early and later stage human bio/medical technology companies.
• Identified, evaluated, and negotiated investment and licensing opportunities
• Chief Scientific Officer for multiple startup biotech/pharma companies
• Developed business plans and long term commercialization strategies for investee companies along with budgets, market projections, HR requirements, regulatory strategy, clinical development plans and project plans
• Focused investee companies on product development and delivered projects on time and on budget
• Selected and guided consultants to the investee companies including marketing, regulatory, product development, legal, etc.
• Led in-depth scientific and market due diligence of potential investments
• Routinely presented new investments to the Scientific and Investment Advisory Committees of the fund
Manager, Product Planning and Development

Viventia Biotech Inc.

(Public Company; 51-200 employees; Biotechnology industry)

1996 — 2002 (6 years)

Viventia is an early stage biotechnology company developing innovative cancer therapeutics based on the human immune system.
• Directed project teams in the design and execution of multi-disciplinary product development plans for recombinant fragments of human monoclonal antibodies from discovery through phase I/II clinical trials.
• Prepared, implemented and monitored timelines, strategic and operational plans and budgets for multiple cross-functional development projects.
• Directed the preparation of regulatory submissions to Health Canada and US FDA.
• Implemented standardized project management templates and techniques including a system to review, approve and track projects to ensure quality and timely completion of projects.
• Negotiated scope of work and costs for external contracts and managed external research collaborations and contracts to successful and timely completion
• Conducted literature, patent, and competitive information searches